Experimental group:Utidelone
Sponsors
Shandong Cancer Hospital and Institute, Sun Yat-sen University Cancer Center
Conditions
Breast cancerprostatic cancer
Phase 2
A single-arm, multicentre, phase II clinical study to evaluate the efficacy and safety of Utidelone Injection in the treatment of recurrent/metastatic HER-2 negative breast cancer
Active, not recruitingChiCTR2200056534
Start: 2022-08-24Updated: 2024-10-07
Phase II clinical study of Utidelone UTD1 in metastatic castration-resistant prostate cancer (mCRPC) after standard treatment failure
RecruitingChiCTR2200058568
Start: 2022-04-06Updated: 2024-01-08